Acelyrin, Inc Common Stock Price Prediction
SLRN Stock | USD 4.57 0.07 1.51% |
Oversold Vs Overbought
39
Oversold | Overbought |
EPS Estimate Next Quarter (0.93) | EPS Estimate Current Year (2.51) | EPS Estimate Next Year (2.13) | Wall Street Target Price 11.1667 | EPS Estimate Current Quarter (0.80) |
Using ACELYRIN, INC hype-based prediction, you can estimate the value of ACELYRIN, INC Common from the perspective of ACELYRIN, INC response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in ACELYRIN, INC to buy its stock at a price that has no basis in reality. In that case, they are not buying ACELYRIN, because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
ACELYRIN, INC after-hype prediction price | USD 4.6 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
ACELYRIN, |
ACELYRIN, INC After-Hype Price Prediction Density Analysis
As far as predicting the price of ACELYRIN, INC at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in ACELYRIN, INC or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of ACELYRIN, INC, with the unreliable approximations that try to describe financial returns.
Next price density |
Expected price to next headline |
ACELYRIN, INC Estimiated After-Hype Price Volatility
In the context of predicting ACELYRIN, INC's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on ACELYRIN, INC's historical news coverage. ACELYRIN, INC's after-hype downside and upside margins for the prediction period are 0.23 and 9.78, respectively. We have considered ACELYRIN, INC's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
ACELYRIN, INC is slightly risky at this time. Analysis and calculation of next after-hype price of ACELYRIN, INC Common is based on 3 months time horizon.
ACELYRIN, INC Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as ACELYRIN, INC is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading ACELYRIN, INC backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with ACELYRIN, INC, there might be something going there, and it might present an excellent short sale opportunity.
Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.13 | 5.18 | 0.03 | 0.09 | 6 Events / Month | 4 Events / Month | In about 6 days |
Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
4.57 | 4.60 | 0.66 |
|
ACELYRIN, INC Hype Timeline
ACELYRIN, INC Common is at this time traded for 4.57. The entity has historical hype elasticity of 0.03, and average elasticity to hype of competition of -0.09. ACELYRIN, is projected to increase in value after the next headline, with the price projected to jump to 4.6 or above. The average volatility of media hype impact on the company the price is over 100%. The price boost on the next news is projected to be 0.66%, whereas the daily expected return is at this time at 0.13%. The volatility of related hype on ACELYRIN, INC is about 756.2%, with the expected price after the next announcement by competition of 4.48. Net Loss for the year was (381.64 M) with profit before overhead, payroll, taxes, and interest of 0. Given the investment horizon of 90 days the next projected press release will be in about 6 days. Check out ACELYRIN, INC Basic Forecasting Models to cross-verify your projections.ACELYRIN, INC Related Hype Analysis
Having access to credible news sources related to ACELYRIN, INC's direct competition is more important than ever and may enhance your ability to predict ACELYRIN, INC's future price movements. Getting to know how ACELYRIN, INC's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how ACELYRIN, INC may potentially react to the hype associated with one of its peers.
HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
IPXXU | Inflection Point Acquisition | 0.00 | 2 per month | 0.00 | (1.23) | 0.28 | 0.00 | 0.65 | |
SABR | Sabre Corpo | 0.05 | 12 per month | 4.49 | 0.08 | 5.33 | (3.43) | 30.83 | |
GFF | Griffon | (4.16) | 7 per month | 1.74 | 0.1 | 3.14 | (3.11) | 22.84 | |
SPNS | Sapiens International | (0.81) | 6 per month | 0.00 | (0.13) | 2.21 | (3.04) | 31.27 | |
HURC | Hurco Companies | (0.42) | 10 per month | 1.44 | 0.13 | 4.37 | (3.00) | 18.87 | |
CECO | CECO Environmental Corp | 1.23 | 9 per month | 3.22 | 0.04 | 4.73 | (3.36) | 18.98 |
ACELYRIN, INC Additional Predictive Modules
Most predictive techniques to examine ACELYRIN, price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for ACELYRIN, using various technical indicators. When you analyze ACELYRIN, charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
About ACELYRIN, INC Predictive Indicators
The successful prediction of ACELYRIN, INC stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as ACELYRIN, INC Common, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of ACELYRIN, INC based on analysis of ACELYRIN, INC hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to ACELYRIN, INC's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to ACELYRIN, INC's related companies. 2010 | 2022 | 2023 | 2024 (projected) | Current Ratio | 8.71 | 10.06 | 8.65 | 10.05 | Net Debt To EBITDA | 2.44 | 4.3 | 0.57 | 0.54 |
Story Coverage note for ACELYRIN, INC
The number of cover stories for ACELYRIN, INC depends on current market conditions and ACELYRIN, INC's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that ACELYRIN, INC is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about ACELYRIN, INC's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
ACELYRIN, INC Short Properties
ACELYRIN, INC's future price predictability will typically decrease when ACELYRIN, INC's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of ACELYRIN, INC Common often depends not only on the future outlook of the potential ACELYRIN, INC's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. ACELYRIN, INC's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding | 70.2 M | |
Cash And Short Term Investments | 721.3 M |
Check out ACELYRIN, INC Basic Forecasting Models to cross-verify your projections. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ACELYRIN, INC. If investors know ACELYRIN, will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ACELYRIN, INC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.46) | Return On Assets (0.33) | Return On Equity (0.42) |
The market value of ACELYRIN, INC Common is measured differently than its book value, which is the value of ACELYRIN, that is recorded on the company's balance sheet. Investors also form their own opinion of ACELYRIN, INC's value that differs from its market value or its book value, called intrinsic value, which is ACELYRIN, INC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ACELYRIN, INC's market value can be influenced by many factors that don't directly affect ACELYRIN, INC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ACELYRIN, INC's value and its price as these two are different measures arrived at by different means. Investors typically determine if ACELYRIN, INC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ACELYRIN, INC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.